Contact the team

eGFR-C study office closure at Easter

The study office will be closed for Easter from 17:00 on Thursday 13th April to 09:00 on Thursday 20th April 2017. During this time the online database will be available as normal.
Please email any SAE forms to

eGFR-C Study Office

eGFR-C Study Office
Birmingham Clinical Trials Unit (BCTU)
Institute of Applied Health Research
College of Medical and Dental Sciences
Public Health Building
University of Birmingham
Birmingham B15 2TT


Fax: 0121 415 9135

Study Manager

  • Hugh Jarrett - 0121 415 8444

Study Co-ordinator

  • Ryan Ottridge - 0121 415 9134/25

Data Manager

  • Adam Khan - 0121 415 9131

Find out more information about our other renal trials

The University of Birmingham Clinical Trials Unit (BCTU) is a research unit specialising in the design, conduct and analysis of clinical trials.

Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: an international randomised controlled trial.

Long-term tapering versus standard prednisolone (steroid) therapy for the treatment of the initial episode of childhood nephrotic syndrome: national multicentre randomised double blind trial

Short course daily prednisolone therapy at the time of upper respiratory tract infection in children with relapsing steroid sensitive nephrotic syndrome.

STOP-ACEi is a multi-centre, randomised controlled trial of Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) withdrawal in advanced kidney disease.


Eculizumab in Shiga-Toxin producing E. Coli Haemolytic Uraemic Syndrome (ECUSTEC): A Randomised, Double Blind, Placebo-Controlled Trial.